The Lancet Microbe (Feb 2022)
WHO international standard for SARS-CoV-2 antibodies to determine markers of protection
- Feng Zhu,
- Thomas Althaus,
- Chee Wah Tan,
- Alizée Costantini,
- Wan Ni Chia,
- Nguyen Van Vinh Chau,
- Le Van Tan,
- Giada Mattiuzzo,
- Nicola J Rose,
- Eric Voiglio,
- Lin-Fa Wang
Affiliations
- Feng Zhu
- Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169657
- Thomas Althaus
- Centre Scientifique de Monaco, Monaco; Direction de l'Action Sanitaire in Monaco, Monaco
- Chee Wah Tan
- Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169657
- Alizée Costantini
- Centre Scientifique de Monaco, Monaco
- Wan Ni Chia
- Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169657
- Nguyen Van Vinh Chau
- Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
- Le Van Tan
- Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam
- Giada Mattiuzzo
- National Institute for Biological Standards and Control, MHRA, South Mimms, UK
- Nicola J Rose
- National Institute for Biological Standards and Control, MHRA, South Mimms, UK
- Eric Voiglio
- Direction de l'Action Sanitaire in Monaco, Monaco
- Lin-Fa Wang
- Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169657; SingHealth Duke-NUS Global Health Institute, Singapore
- Journal volume & issue
-
Vol. 3,
no. 2
pp. e81 – e82